Lyson Medical Technology is proud to have been awarded the Academia-Industry Innovation Award at the 21st National Innovation Awards in 2024, one of Taiwan’s most prestigious honors in the biomedical and healthcare innovation sector. This recognition reflects not only our technical achievements but also our ongoing commitment to turning bold ideas into impactful solutions.

​

Addressing Training Gaps with Realistic, Biomimetic Simulation Models

At Lyson, we focus on solving long-standing challenges in minimally invasive surgical training through the development of high-fidelity prosthetic models. Our core innovation lies in a proprietary protein-mimicking material, engineered in-house to realistically replicate the tactile and mechanical behavior of human tissue. These models offer a lifelike preclinical training experience, enabling healthcare professionals to practice with higher accuracy and reduced risk.

By providing a realistic, responsive training environment, our solutions directly address critical pain points such as limited training resources and high clinical risk, helping to build a safer, more efficient medical education ecosystem.

​

Innovation Beyond R&D—A Commitment to Clinical Impact

Winning the National Innovation Award represents a powerful affirmation of Lyson’s mission to bridge academic research with industrial application through scalable, real-world solutions. We believe innovation only holds true value when it translates into clinical practice and medical education, solving real problems in real environments.

Moving forward, Lyson will continue to pursue our mission:
“To make every medical training experience as close to clinical reality as possible.”
We are dedicated to collaborating with academic institutions, teaching hospitals, and industry partners to create smarter, safer, and more effective training platforms—driving medical innovation onto the global stage.

​

About the National Innovation Awards

Founded in 2003 by the Institute for Biotechnology and Medicine Industry (IBMI), the National Innovation Awards are among Taiwan’s top recognitions for excellence in biomedical and healthcare innovation. Awards are given across multiple categories—including Corporate Innovation, Startup Innovation, Clinical Innovation, and Academia-Industry Innovation.

The Academia-Industry Innovation Award specifically recognizes groundbreaking technologies and commercialization efforts from universities and research institutions. Winning entries are selected through a rigorous evaluation process based on criteria such as technological innovation, industrial potential, and societal impact. The award serves as a key benchmark for cutting-edge biomedical development in Taiwan.